Lalitha Sivaswamy
Neurology with Special Qualifications in Child Neurology · Macon, GANPI 1427095082
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,177 and has fallen 85.9% since, to $165 in 2025.
Across 62 payments — averaging $43.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$603
- UCB, Inc.$429
- Livanova USA, Inc.$332
- Jazz Pharmaceuticals Inc.$165
- Eisai Inc.$162
- Neuropace, Inc.$154
- plus $838 from 15 others
Across 26 payments — averaging $2161.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- PTC Therapeutics, Inc.$56K
What the payments were for
- Food & beverage$2,66099%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 12 | $603 |
| UCB, Inc. | 12 | $429 |
| Livanova USA, Inc. | 8 | $332 |
| Jazz Pharmaceuticals Inc. | 3 | $165 |
| Eisai Inc. | 3 | $162 |
| Neuropace, Inc. | 1 | $154 |
| Catalyst Pharmaceuticals, Inc. | 2 | $150 |
| PTC Therapeutics, Inc. | 1 | $138 |
| Mallinckrodt Enterprises LLC | 1 | $106 |
| Sanofi | 2 | $71 |
| Pyros Pharmaceuticals, Inc. | 1 | $70 |
| Aquestive Therapeutics, Inc. | 4 | $60 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Biocodex, Inc. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Immedica Pharma US, Inc. | 1 | $30 |
| AbbVie | 1 | $30 |
| SK Life Science, Inc. | 1 | $21 |
| Sarepta Therapeutics, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Zogenix Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fycompa$250
- VALTOCO$232
- RNS Neurostimulator Kit$154
- EMFLAZA$138
- VNS Therapy$133
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$133
- Nayzilam$125
- Epidiolex$122
- Fintepla$115
- ACTHAR$106
How this compares
$2,682 in reported general payments places this provider in the 55th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
See all neurology with special qualifications in child neurology providers in Georgia →
Other neurology with special qualifications in child neurology in Macon
- Joseph TrasmonteMacon$452
- John HemphillSavannah$2M
- Chaouki KhouryAtlanta$978K
- Katherine MoretzSavannah$144K
- Yong ParkAugusta$78K
- Daniel TarquinioGainesville$50K
- Han PhanAtlanta$44K
- Raymond ChengAtlanta$40K
- Sonam BhallaAtlanta$23K
- Cherise FrazierAtlanta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.